Last reviewed · How we verify
Micronized progesterone 200 MG — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Micronized progesterone 200 MG (Micronized progesterone 200 MG) — Andros Day Surgery Clinic.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Micronized progesterone 200 MG TARGET | Micronized progesterone 200 MG | Andros Day Surgery Clinic | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Micronized progesterone 200 MG CI watch — RSS
- Micronized progesterone 200 MG CI watch — Atom
- Micronized progesterone 200 MG CI watch — JSON
- Micronized progesterone 200 MG alone — RSS
Cite this brief
Drug Landscape (2026). Micronized progesterone 200 MG — Competitive Intelligence Brief. https://druglandscape.com/ci/micronized-progesterone-200-mg. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab